Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Key

Executive Summary

Theo-Dur sales in the U.S. grew 43% in 1983 to $65 mil., with Theo-Dur Sprinkle contributing another $4 mil. in sales last year, the firm said in its annual report for 1983. Together, the two Theo-Dur products increased their share of the xanthine bronchodilator market from 29% to 40%, Key noted. The firm reported that Nitro-Dur sales increased 80% in 1983 to $48 mil.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS006566

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel